Td Private Client Wealth LLC Biogen Inc. Transaction History

Td Private Client Wealth LLC

$4.07 Trillion
Q2 2025

A detailed history of Td Private Client Wealth LLC transactions in Biogen Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 338 shares of BIIB stock, worth $51,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares

338

Previous 12 2716.67%

Holding current value

$51,027

Previous $1.64 Million 2485.2%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	BUY	$113.38 - $135.49 $36,961 - $44,169	326 Added 2716.67%	338 $42.4 Million
Q1 2025 Apr 29, 2025	SELL	$133.43 - $153.27 $5,337 - $6,130	-40 Reduced 76.92%	12 $1.64 Million
Q4 2024 Feb 11, 2025	SELL	$146.47 - $191.55 $48,774 - $63,786	-333 Reduced 86.49%	52 $7.95 Million
Q3 2024 Nov 18, 2024	BUY	$189.07 - $236.8 $14,558 - $18,233	77 Added 25.0%	385 $74.6 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $58,680 - $72,909	308 New	308 $71.4 Million
Q1 2024 Aug 16, 2024	SELL	$212.02 - $267.71 $593,019 - $748,784	-2,797 Reduced 89.28%	336 $72.5 Million
Q4 2023 Aug 16, 2024	SELL	$222.59 - $267.94 $65,441 - $78,774	-294 Reduced 8.58%	3,133 $811 Million
Q3 2023 Aug 16, 2024	SELL	$253.3 - $285.89 $243,421 - $274,740	-961 Reduced 21.9%	3,427 $881 Million
Q2 2023 Aug 16, 2024	SELL	$275.25 - $318.06 $79,547 - $91,919	-289 Reduced 6.18%	4,388 $1.25 Billion
Q1 2023 Aug 16, 2024	SELL	$256.56 - $292.34 $53,877 - $61,391	-210 Reduced 4.3%	4,677 $1.3 Billion
Q4 2022 Aug 16, 2024	SELL	$252.44 - $306.72 $206,495 - $250,896	-818 Reduced 14.34%	4,887 $1.35 Billion
Q3 2022 Aug 16, 2024	SELL	$194.69 - $268.46 $9,150 - $12,617	-47 Reduced 0.82%	5,705 $1.52 Billion
Q2 2022 Aug 16, 2024	BUY	$187.54 - $223.02 $135,778 - $161,466	724 Added 14.4%	5,752 $1.17 Billion
Q1 2022 Aug 16, 2024	BUY	$193.77 - $244.14 $924,864 - $1.17 Million	4,773 Added 1871.76%	5,028 $1.06 Billion
Q4 2021 Aug 16, 2024	SELL	$223.92 - $287.77 $14,106 - $18,129	-63 Reduced 19.81%	255 $61.2 Million
Q3 2021 Aug 16, 2024	BUY	$282.99 - $369.05 $2,829 - $3,690	10 Added 3.25%	318 $90 Million
Q2 2021 Aug 16, 2024	BUY	$259.0 - $414.71 $6,216 - $9,953	24 Added 7.55%	342 $118 Million
Q1 2021 Aug 16, 2024	BUY	$242.95 - $284.63 $6,802 - $7,969	28 Added 9.66%	318 $89 Million
Q4 2020 Aug 16, 2024	SELL	$236.26 - $355.63 $26,697 - $40,186	-113 Reduced 28.04%	290 $71 Million
Q3 2020 Aug 16, 2024	SELL	$264.77 - $305.71 $75,988 - $87,738	-287 Reduced 41.59%	403 $114 Million
Q2 2020 Aug 16, 2024	SELL	$258.66 - $342.55 $33,884 - $44,874	-131 Reduced 15.96%	690 $185 Million
Q1 2020 Aug 16, 2024	SELL	$268.85 - $341.04 $537,431 - $681,738	-1,999 Reduced 70.89%	821 $260 Million
Q4 2019 Aug 16, 2024	BUY	$220.06 - $304.07 $552,790 - $763,823	2,512 Added 815.58%	2,820 $837 Million

Others Institutions Holding BIIB

# of Institutions

1,022

Shares Held

131M

Call Options Held

2.87M

Put Options Held

2.57M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Biogen Inc. Transaction History